Puneet Souda
Stock Analyst at Leerink Partners
(1.99)
# 3,002
Out of 5,182 analysts
196
Total ratings
47.85%
Success rate
-0.88%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $170 → $180 | $82.21 | +118.95% | 8 | Feb 20, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $545 → $580 | $514.23 | +12.79% | 20 | Oct 22, 2025 | |
| CYRX Cryoport | Upgrades: Outperform | $16 | $9.64 | +65.98% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $7.20 | +66.67% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $3.39 | +135.99% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $8.00 | +12.50% | 10 | Apr 30, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $4.59 | +357.52% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $32.44 | +23.30% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $201.90 | -25.71% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $324.68 | +15.50% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $23.53 | +48.75% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $117.50 | +23.40% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $195.87 | +53.16% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $126.96 | +96.91% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $57.53 | +91.20% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $122.59 | +63.15% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $3.66 | +391.80% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.46 | +310.96% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $50.38 | -40.45% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $39.05 | +122.79% | 13 | May 5, 2022 |
Guardant Health
Feb 20, 2026
Maintains: Outperform
Price Target: $170 → $180
Current: $82.21
Upside: +118.95%
Thermo Fisher Scientific
Oct 22, 2025
Maintains: Outperform
Price Target: $545 → $580
Current: $514.23
Upside: +12.79%
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $9.64
Upside: +65.98%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $7.20
Upside: +66.67%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $3.39
Upside: +135.99%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $8.00
Upside: +12.50%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $4.59
Upside: +357.52%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $32.44
Upside: +23.30%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $201.90
Upside: -25.71%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $324.68
Upside: +15.50%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $23.53
Upside: +48.75%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $117.50
Upside: +23.40%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $195.87
Upside: +53.16%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $126.96
Upside: +96.91%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $57.53
Upside: +91.20%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $122.59
Upside: +63.15%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $3.66
Upside: +391.80%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.46
Upside: +310.96%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $50.38
Upside: -40.45%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $39.05
Upside: +122.79%